The Near Future Report Review: Is Jeff Brown Legit?

Because of Jeff's personal experience with this medical technology, he thinks it can change the world: "it's an unbelievable brand-new pattern in medication driven by innovation that identified cancer. And provided me a combating opportunity to beat it extremely early prior to it became a possibly fatal problem." Jeff doesn't just advise buying this company to take advantage of this trend.

: "However there's more to this technology than just saving my life. By subscribing to The Near Future Report today, you can discover how this technology works, what it does, and why Jeff believes it will change the world of medicine.


"There's Biolife Sciences, which rose as high as 41,800% in less than a year, A small, $1,000 stake could have brought back as much as $418,000." The sales page is filled with similar gains. Jeff Brown uses Mirati Therapies as an example, which increased 8,481% in under two years. Other gains featured on The Near Future Report's sales page consist of: Jeff Brown is careful to discuss that previous incomes do not ensure future outcomes.

He does not recommend designating a significant part of your portfolio to these stocks. However, Jeff also declares he has "checked out suppliers and done his own research on future profits" to confirm his recommendations. Based upon that analysis, Jeff is confident that a few of his biotech stock picks will increase significantly in the future.

2 Trillion Industry that Could Save Millions of Lives? Jeff, like numerous investors, believes biotech will be one of the hottest tech trends over the coming years. Biotech is no trick.

Jeff mentions precision medicine as one example: "the biotech market is expected to grow 86% over the next couple of years. That is impressive. But listen to this, The precision medication market is expected to grow 152% during that same time" Precision medicine is an emerging area of biotech that uses precise biological information to determine disease danger.